Intranasal administration of beta-interferon in rabbits
Maitani, Y.; Igawa, T.; Machida, Y.; Nagai, T.
Drug Design and Delivery 1(1): 65-70
1986
ISSN/ISBN: 0884-2884 PMID: 3509321 Document Number: 280225
beta-Interferon (IFN) administered intranasally in solution or as a powder without surfactants was not absorbed in rabbits. However, absorption occurred after the addition of surfactants (non-ionic, anionic and amphoteric). Maximum concentrations of IFN in plasma were dependent on the surfactant used, sodium glycocholate being the most effective. Total absorption of IFN following nasal administration with sodium glycocholate was 2.2% of that following intravenous administration.
Document emailed within 1 workday
Related Documents
Fischer, J. 2000: Chronic administration of intranasal beclomethasone (Beconasol), but not intranasal mometasone (Nasonex) slows growth in body height Praxis 89(38): 1526Gomi, K.; Morimoto, M.; Inoue, A.; Kobayashi, H.; Deguchi, T.; Hara, T.; Nakamizo, N. 1984: Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits Gan 75(3): 292-300
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Takashima, S.; Doihara, H.; Yokoyama, N.; Tanada, M.; Soga, H.; Kurita, A.; Takiyama, W.; Saeki, H.; Moriwaki, S. 1990: Intraperitoneal administration of recombinant interferon-beta for prevention in peritoneal metastasis of gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Pt 2): 1600-1603
Notsuka, T.; Furusawa, M.; Tomoda, H.; Seo, Y.; Kurashige, S.; Kameda, K.; Sonoda, T. 1986: Intraperitoneal administration of beta-interferon in gastric cancer patients with peritoneal recurrence (ascites and serum IFN levels and its antitumor effect) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3538-3540
Onozaki, K.; Urawa, H.; Tamatani, T.; Iwamura, Y.; Hashimoto, T.; Baba, T.; Suzuki, H.; Yamada, M.; Yamamoto, S.; Oppenheim, J.J. 1988: Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor Journal of Immunology 140(1): 112-119
Sumpio, B.E.; Ernstoff, M.S.; Kirkwood, J.M. 1984: Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment Cancer Research 44(8): 3599-3603
DeLong, D.; Manning, P.J.; Gunther, R.; Swanson, D.L. 1992: Colonization of rabbits by Pasteurella multocida: serum IgG responses following intranasal challenge with serologically distinct isolates Laboratory Animal Science 42(1): 13-18
Weinberg, J.M.; Wolfe, J.T.; Sood, S.; Saruk, M.; Rook, A.H.; Spiers, E.M. 1997: Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature Acta Dermato-Venereologica 77(2): 146-148
Li, Q.; Kong, P.; Wu, C.-X.; Sun, C.-W.; Chen, Y.-L.; Xu, X.-Q.; Zhang, D.-L. 2011: Effects of intranasal interferon gamma on transforming growth factor-β1/Smad in rats with allergic rhinitis Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46(1): 59-62
Ahrens, P. 2004: Administration times for intranasal drops Medizinische Monatsschrift für Pharmazeuten 27(1): 23-24
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Czepita, D. 1990: Experimental studies of the role of the adrenergic system in the development of bioelectric response of the retina and visual cortex. IV. Visual evoked potentials in rabbits after administration of alpha and beta receptor agonists and blockaders Klinika Oczna 92(7-8): 127-128
Dohzaki, S.; Kaseno, S.; Gotoh, Y. 1983: Control of circulation with intranasal administration of nitroglycerin Masui. Japanese Journal of Anesthesiology 32(6): 645-652
Mahajan, P.M.; Jadhav, V.H.; Jogaikar, D.G.; Mehta, J.M. 2000: Intranasal administration of fusidic acid cream in leprosy Indian Journal of Leprosy 72(4): 451-455
Vinogradov, V.A.; Kalenikova, E.I.; Sokolov, A.S. 1988: Bioavailability of dalargin and its metabolism during intranasal administration to rats Biulleten' Eksperimental'noi Biologii i Meditsiny 106(7): 48-50
Wang, J.; Bu, G. 2000: Influence of the nasal mucociliary system on intranasal drug administration Chinese Medical Journal 113(7): 647-649
Genazzani, A.R.; Cappagli, B.; Ciaponi, M. 2003: Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview Minerva Ginecologica 55(3): 189-200
Baturina, E.I.; Sarycheva, N.I.; Deĭgin, V.I.; Iarova, E.P.; Kamenskiĭ, A.A. 1988: Paradoxical correlations of the effectiveness of the intranasal and intraperitoneal administration of dermorphins in rats Biulleten' Eksperimental'noi Biologii i Meditsiny 105(2): 177-179
Lethagen, S.; Harris, A.S.; Sjörin, E.; Nilsson, I.M. 1987: Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility Thrombosis and Haemostasis 58(4): 1033-1036